EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Therapeutic hypothermia reprograms nanocarrier protein corona via apolipoprotein C1 enrichment for precision cardiovascular therapy

Chenwen Li iD, Guanli Zhao, Yuantong Qi, Menglong Sun, Ling Zhong, Qinghua Yang, Kaiyao Hu, Juan Cheng, Yin Dou, Yingxue Hao, Jianxiang Zhang iD

Proceedings of the National Academy of Sciences · 18.11.2025 · 122 (46)

DOI: 10.1073/pnas.2515072122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 13.11.2025. Verfasst von Chenwen Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China. Hauptthemen laut MEDLINE: Nanoparticles, Cardiovascular Diseases, Hypothermia, Induced, Protein Corona. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), New Chongqing Youth Innovative Talent Program, Key Program for Technological Innovation & Application Development of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs), the primary cause of global mortality, face persistent therapeutic challenges due to poor drug targeting and systemic side effects. While innovative nanotherapeutic approaches offer improved drug delivery through targeting and stimulus-responsive release mechanisms, clinical translation is limited by poor tissue specificity and manufacturing limitations. We present a universal therapeutic hypothermia (TH, i.e., 32 to 35 °C)-enhanced strategy that amplifies nanocarrier targeting across multiple CVD models. Both hard and soft nanocarriers showed 1.6- to 3-fold increased pathological tissue accumulation under TH versus normothermia, correlating with enhanced therapeutic efficacy in multiple murine models of CVDs, including heart failure, myocardial hypertrophy, ventricular fibrillation, ischemic stroke, atherosclerosis, and deep vein thrombosis. Mechanistically, TH induces temperature-dependent enrichment of apolipoproteins C1 (ApoC1) and C4 in the protein corona of nanoparticle surface, enabling receptor-mediated targeting through upregulated lipoprotein receptors in injured cardiovascular tissues. Notably, ApoC1-mediated targeting outperformed established cardiac-targeting peptides in directing nanoparticles to diseased hearts. The TH-driven approach and direct ApoC1 functionalization provide a straightforward, scalable, and cost-effective approach to enhance nanotherapy precision for CVD treatment, potentially addressing critical barriers in clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesCardiovascular DiseasesHypothermia, InducedProtein CoronaApolipoprotein C-IAnimalsMiceDisease Models, AnimalDrug Delivery SystemsHumansMaleMice, Inbred C57BLDrug Carriers

Stichwörter der Autor:innen

ApoC1 decorationcardiovascular diseasesprotein coronatargeted therapytherapeutic hypothermia

Substanzen

Protein CoronaApolipoprotein C-IDrug Carriers

Autor:innen und Institutionen

  • Department of Vascular Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • Department of Pharmaceutics, College of Pharmacy, Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • Yu-Yue Pathology Scientific Research Center, Jiulongpo District, Chongqing 400039, China.
  • State Key Laboratory of Trauma and Chemical Poisoning, Third Military Medical University (Army Medical University), Chongqing 400038, China.

ORCID-Profile: Chenwen Li, Jianxiang Zhang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • New Chongqing Youth Innovative Talent Program
  • Key Program for Technological Innovation & Application Development of Chongqing
  • Key Medical Program Integrated by Chongqing Science and Technology Bureau and Chongqing Health Commission
  • Graduate Supervisor Team Program of Chongqing in 2022

Zitieren

APA

Li, C., Zhao, G., Qi, Y., Sun, M., Zhong, L., Yang, Q., Hu, K., Cheng, J., Dou, Y., Hao, Y., & Zhang, J. (2025). Therapeutic hypothermia reprograms nanocarrier protein corona via apolipoprotein C1 enrichment for precision cardiovascular therapy. Proceedings of the National Academy of Sciences, 122(46). https://doi.org/10.1073/pnas.2515072122

Vancouver

Li C, Zhao G, Qi Y, Sun M, Zhong L, Yang Q, et al. Therapeutic hypothermia reprograms nanocarrier protein corona via apolipoprotein C1 enrichment for precision cardiovascular therapy. Proceedings of the National Academy of Sciences. 2025;122(46). doi:10.1073/pnas.2515072122

BibTeX
@article{Li2025,
  author = {Li, Chenwen and Zhao, Guanli and Qi, Yuantong and Sun, Menglong and Zhong, Ling and Yang, Qinghua and Hu, Kaiyao and Cheng, Juan and Dou, Yin and Hao, Yingxue and Zhang, Jianxiang},
  title = {Therapeutic hypothermia reprograms nanocarrier protein corona via apolipoprotein C1 enrichment for precision cardiovascular therapy},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {46},
  doi = {10.1073/pnas.2515072122}
}
Kostenlos starten →